Literature DB >> 11284816

Postoperative residual block after intermediate-acting neuromuscular blocking drugs.

A H Hayes1, R K Mirakhur, D S Breslin, J E Reid, K C McCourt.   

Abstract

The frequency and duration of postoperative residual neuromuscular block on arrival of 150 patients in the recovery ward following the use of vecuronium (n = 50), atracurium (n = 50) and rocuronium (n = 50) were recorded. Residual block was defined as a train-of-four ratio of <0.8. An additional group of 10 patients received no neuromuscular blocking drugs during anaesthesia. The incidence of postoperative residual neuromuscular block was 64%, 52% and 39% after the use of vecuronium, atracurium and rocuronium, respectively. Similar numbers of patients were not able to maintain a sustained head or leg lift for 5 s on arrival in the recovery ward. The mean [range] times to attaining a train-of-four ratio of > or =0.8 after arrival in the recovery ward were 9.2 [1-61], 6.9 [1-24] and 14.7 [1.5-83] min for vecuronium, atracurium and rocuronium, respectively. None of the 10 patients who did not receive neuromuscular blocking drugs had train-of-four ratios <0.8 on arrival in the recovery ward. It is concluded that a large proportion of patients arrive in the recovery ward with a train-of-four ratio <0.8, even with the use of intermediate-acting neuromuscular blocking drugs. Although the residual block is relatively short lasting, it may occasionally be prolonged, requiring close observation and monitoring of such patients in the recovery ward.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284816     DOI: 10.1046/j.1365-2044.2001.01921.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  26 in total

1.  Retrospective analysis of spontaneous recovery from neuromuscular blockade produced by empirical use of rocuronium.

Authors:  Hiroto Yamamoto; Tokujiro Uchida; Yudai Yamamoto; Yusuke Ito; Koshi Makita
Journal:  J Anesth       Date:  2011-09-21       Impact factor: 2.078

2.  Effective method of continuous rocuronium administration based on effect-site concentrations using a pharmacokinetic/pharmacodynamic model during propofol-remifentanil anesthesia.

Authors:  Takahiro Moriyama; Akira Matsunaga; Osamu Nagata; Kei Enohata; Tomomi Kamikawaji; Erika Uchino; Yuichi Kanmura
Journal:  J Anesth       Date:  2015-03-01       Impact factor: 2.078

3.  A Comparision of the Effect of Sugammadex on the Recovery Period and Postoperative Residual Block in Young Elderly and Middle-Aged Elderly Patients.

Authors:  Emine Yazar; Canan Yılmaz; Hülya Bilgin; Derya Karasu; Selcan Bayraktar; Yılmaz Apaydın; Halil Erkan Sayan
Journal:  Balkan Med J       Date:  2016-03-01       Impact factor: 2.021

Review 4.  Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.

Authors:  Ana-Marija Hristovska; Patricia Duch; Mikkel Allingstrup; Arash Afshari
Journal:  Cochrane Database Syst Rev       Date:  2017-08-14

5.  Neuromuscular blockade improves surgical conditions (NISCO).

Authors:  Manfred Blobner; Christiane G Frick; Roland B Stäuble; Hubertus Feussner; Stefan J Schaller; Christoph Unterbuchner; Charlotte Lingg; Martina Geisler; Heidrun Fink
Journal:  Surg Endosc       Date:  2014-08-15       Impact factor: 4.584

6.  Respiratory events with sugammadex vs. neostigmine following laparoscopic sleeve gastrectomy: a prospective pilot study assessing neuromuscular reversal strategies.

Authors:  Shmuel Evron; Yuri Abelansky; Tiberiu Ezri; Alexander Izakson
Journal:  Rom J Anaesth Intensive Care       Date:  2017-10

7.  Neuromuscular Block and Blocking Agents in 2018.

Authors:  Christoph Unterbuchner
Journal:  Turk J Anaesthesiol Reanim       Date:  2018-04-01

8.  Residual Paralysis: Does it Influence Outcome After Ambulatory Surgery?

Authors:  Hassan Farhan; Ingrid Moreno-Duarte; Duncan McLean; Matthias Eikermann
Journal:  Curr Anesthesiol Rep       Date:  2014-12

9.  Discovery, development, and clinical application of sugammadex sodium, a selective relaxant binding agent.

Authors:  Mark Welliver; John McDonough; Nicholas Kalynych; Robert Redfern
Journal:  Drug Des Devel Ther       Date:  2009-02-06       Impact factor: 4.162

10.  Residual Curarization and Postoperative Respiratory Complications Following Laparoscopic Sleeve Gastrectomy. The Effect of Reversal Agents: Sugammadex vs. Neostigmine.

Authors:  Tiberiu Ezri; Shmuel Evron; Irina Petrov; Pinhas Schachter; Yitzhak Berlovitz; Mordechai Shimonov
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.